Marquette Asset Management LLC Acquires New Stake in Church & Dwight Co., Inc. (NYSE:CHD)

Marquette Asset Management LLC purchased a new position in shares of Church & Dwight Co., Inc. (NYSE:CHD) during the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 2,435 shares of the company’s stock, valued at approximately $255,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Millennium Management LLC boosted its stake in Church & Dwight by 1,617.3% in the 2nd quarter. Millennium Management LLC now owns 1,292,854 shares of the company’s stock worth $134,043,000 after buying an additional 1,217,568 shares during the last quarter. Marshall Wace LLP raised its position in shares of Church & Dwight by 4,161.5% in the 2nd quarter. Marshall Wace LLP now owns 1,100,410 shares of the company’s stock worth $114,091,000 after buying an additional 1,074,588 shares during the period. Capital Research Global Investors acquired a new position in Church & Dwight in the first quarter valued at $69,384,000. Vanguard Group Inc. grew its position in Church & Dwight by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 30,265,072 shares of the company’s stock valued at $2,861,865,000 after acquiring an additional 354,946 shares during the period. Finally, Goldman Sachs Group Inc. raised its holdings in shares of Church & Dwight by 26.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,334,950 shares of the company’s stock worth $126,233,000 after purchasing an additional 277,017 shares during the period. 86.60% of the stock is currently owned by hedge funds and other institutional investors.

Church & Dwight Trading Up 1.0 %

Shares of NYSE:CHD opened at $100.09 on Wednesday. The firm has a market cap of $24.47 billion, a P/E ratio of 31.77, a P/E/G ratio of 3.74 and a beta of 0.54. The company has a current ratio of 1.53, a quick ratio of 0.98 and a debt-to-equity ratio of 0.51. Church & Dwight Co., Inc. has a twelve month low of $82.25 and a twelve month high of $110.31. The company has a 50 day moving average of $102.30 and a 200-day moving average of $104.13.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings data on Friday, August 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.09. The company had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.51 billion. Church & Dwight had a net margin of 13.38% and a return on equity of 19.86%. The business’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.92 EPS. As a group, analysts anticipate that Church & Dwight Co., Inc. will post 3.43 earnings per share for the current fiscal year.

Church & Dwight Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 3rd. Shareholders of record on Thursday, August 15th were issued a dividend of $0.2838 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.14 annualized dividend and a yield of 1.13%. Church & Dwight’s payout ratio is presently 35.87%.

Wall Street Analysts Forecast Growth

CHD has been the subject of several research reports. Wells Fargo & Company decreased their price objective on shares of Church & Dwight from $116.00 to $108.00 and set an “overweight” rating for the company in a research note on Monday, August 5th. Morgan Stanley lowered Church & Dwight from an “overweight” rating to an “equal weight” rating and set a $110.00 target price for the company. in a research note on Monday, September 9th. BNP Paribas began coverage on shares of Church & Dwight in a research report on Monday, June 24th. They issued a “neutral” rating and a $114.00 price objective for the company. Argus upped their target price on shares of Church & Dwight from $115.00 to $125.00 and gave the company a “buy” rating in a research note on Tuesday, June 11th. Finally, TD Cowen started coverage on shares of Church & Dwight in a research note on Tuesday, July 23rd. They set a “buy” rating and a $116.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $107.25.

Insider Buying and Selling at Church & Dwight

In related news, EVP Barry A. Bruno sold 59,328 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $99.37, for a total value of $5,895,423.36. Following the completion of the sale, the executive vice president now owns 4,319 shares in the company, valued at approximately $429,179.03. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.00% of the company’s stock.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.